Navigation Links
IMA wants members not to do sex determination tests during pregnancy

The Indian Medical Association has asked its members to refrain from conducting sex-determination tests and aiding female foeticide. No support would be extended to practitioners caught in the act, the IMA said on Sunday. "We as an organisation should warn our members against aiding in such heinous crimes", said Dr. Vinay Agarwal, joint secretary, IMA headquarters, New Delhi.

He was speaking at a regional workshop on female foeticide and infanticide organised by the IMA, Tambaram, with support from the IMA headquarters and the UNICEF here.

Dr. P. K. Kesavan, IMA State president, said the organisation was concerned over the issue and was committed to rooting out female foeticide. The IMA and non-governmental organisations should work in cooperation with each other and a continuous monitoring and reporting mechanism should be evolved. Dr. Ketan Desai, IMA national president, said an awareness drive should be launched to prevent female foeticide and infanticide.

Mr. L. K. Tripathy, Health Secretary, pointed to three indicators in the census 2001 and said the situation in the State had improved compared to the previous decade.

Ms. Sabitha Naqvi, from UNICEF, New Delhi, stressed the importance of roping celebrities and film personalities into the anti-foeticide campaign. Mrs. Latha Rajanikanth, correspondent, Ashram School, Chennai, lighted a traditional lamp to mark the inauguration. Dr. Sheela Ramani, treasurer, IMA, Tambaram, Dr. Sanjeev Malik, secretary, IMA, New Delhi, Dr. M. Balasubramanian, programme coordinator, and Mr. Thomas George, from UNICEF, Chennai, highlighted various aspects of the problem.

Courtesy : The Hindu
'"/>




Page: 1

Related medicine news :

1. Students wants to extent Tution waiver in Ontario
2. Catherine Zeta wants to give up nicotine cravings
3. Invest on gym memberships
4. Religious Leaders condemn determination of sex in hospitals
5. Doctors advice early anemia tests
6. Genetic tests for cancer
7. Space research leads to needle-free blood tests
8. Early diagnosis for autism from blood tests may be possible
9. Skin tests confirms cancer
10. Genetically modified rice faces strong protests in Asia
11. Child specific HIV drugs and laboratory tests should be developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: